Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
E2F8 encodes a member of a family of transcription factors which regulate the expression of genes required for progression through the cell cycle. Zusätzlich bieten wir Ihnen E2F8 Proteine (3) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 44 products:
Human Monoclonal E2F8 Primary Antibody für ELISA, WB - ABIN566378
Li, Ran, Li, Gordon, Comstock, Siddiqui, Cleghorn, Chen, Kornacker, Liu, Pandit, Khanizadeh, Weinstein, Leone, de Bruin: Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development. in Developmental cell 2008
Show all 4 Pubmed References
Human Polyclonal E2F8 Primary Antibody für ELISA, WB - ABIN450055
Lui, Baron: Evidence that Igf2 down-regulation in postnatal tissues and up-regulation in malignancies is driven by transcription factor E2f3. in Proceedings of the National Academy of Sciences of the United States of America 2013
Show all 2 Pubmed References
Study provides evidence that E2F8 functions as a proliferation-related oncogene (zeige RAB1A Antikörper) in papillary thyroid cancer progression. Moreover, miR (zeige MLXIP Antikörper)-144 appears to be a tumor suppressor through direct inhibition of E2F8.
Results showed that E2F8 is up-regulated in metastatic prostate cancer and associated with poor prognosis. These results indicate that E2F8 is a crucial transcription regulator controlling cell cycle and survival in prostate cancer cells.
E2F8-mediated transcriptional repression is a critical tumor suppressor mechanism during postnatal liver development
transcription factor E2F8 is involved in the polyploidization during mouse and human decidualization
E2F8 is overexpressed in Lung Cancer and is required for the growth of LC cells. E2F8 knockdown reduced the expression of UHRF1 (zeige UHRF1 Antikörper). These findings implicate E2F8 as a novel therapeutic target for LC treatment.
The results identify E2F8 as a repressor and E2F1 (zeige E2F1 Antikörper) as an activator of a transcriptional network controlling polyploidization in mammalian cells.
Analyses indicated that E2F8 could bind to regulatory elements of cyclin D1 (zeige CCND1 Antikörper), regulating its transcription and promoting accumulation of S-phase cells. Findings suggest that E2F8 contributes to the oncogenic potential of HCC (zeige FAM126A Antikörper)
The similarities between E2F-7 (zeige E2F7 Antikörper) and E2F-8 define a new subgroup of the E2F (zeige E2F1 Antikörper) family, and further imply that E2F-7 (zeige E2F7 Antikörper) and E2F-8 may act through overlapping mechanisms in mediating cell cycle control.
E2F8 may have an important role in repressing the expression of E2F (zeige E2F1 Antikörper)-target genes in the S-phase of the cell cycle.
E2F7 (zeige E2F7 Antikörper) and E2F8 act upstream of E2F1 (zeige E2F1 Antikörper), and influence the ability of cells to undergo a DNA-damage response.
Rb and E2F8 collaborate to promote DNA replication.
The specificity of E2F8 in mediating Rb function in erythropoiesis suggests a critical and overlapping roles of Rb and E2f8 in maintaining normal erythropoiesis and in preventing hemolysis.
Overexpression of E2F8 significantly slows down the proliferation of primary mouse embryonic fibroblasts.
Results identify E2F7 (zeige E2F7 Antikörper) and E2F8 as a unique repressive arm of the E2F (zeige E2F1 Antikörper) transcriptional network that is critical for embryonic development.
This gene encodes a member of a family of transcription factors which regulate the expression of genes required for progression through the cell cycle. The encoded protein regulates progression from G1 to S phase by ensuring the nucleus divides at the proper time. Multiple alternatively spliced variants, encoding the same protein, have been identified.
E2F transcription factor 8
, E2F family member 8
, transcription factor E2F8
, transcription factor E2F8-like
, E2f family member 8